scholarly journals 1435TiP Adjuvant immunotherapy for resected esophageal squamous cell carcinoma with high risk of recurrence (AIRES): A multicenter, open-label, randomized, controlled phase III trial

2021 ◽  
Vol 32 ◽  
pp. S1072-S1073
Author(s):  
X. Kang ◽  
J. Xu ◽  
R. Zhang ◽  
Y. Song ◽  
Z. Wang ◽  
...  
Sign in / Sign up

Export Citation Format

Share Document